Where does Mallinckrodt Nuclear Medicine LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Mallinckrodt Nuclear Medicine LLC ranks #26,794 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Mallinckrodt Nuclear Medicine LLC hold?

Mallinckrodt Nuclear Medicine LLC holds 10 US utility patents granted between 2016 and 2019, spanning 16 technology areas.

What is Mallinckrodt Nuclear Medicine LLC's Innovation Score?

Mallinckrodt Nuclear Medicine LLC has an Innovation Score of 34.4 out of 100 (48th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Mallinckrodt Nuclear Medicine LLC focus on?

Mallinckrodt Nuclear Medicine LLC's top technology area is G21G (Conversion OF Chemical ELEMENTS; Radioactive Sources) with 7 patents, ranking #13 of 83 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

Is Mallinckrodt Nuclear Medicine LLC's patent grant rate increasing or decreasing?

Mallinckrodt Nuclear Medicine LLC's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Mallinckrodt Nuclear Medicine LLC's patents?

Mallinckrodt Nuclear Medicine LLC's patents average 20.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Mallinckrodt Nuclear Medicine LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Mallinckrodt Nuclear Medicine LLC

USPTO PatentsView assignee record - 10 granted patents across 16 technology areas, recorded in grant years 2016–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G21G (Conversion OF Chemical ELEMENTS; Radioactive Sources).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Mallinckrodt ranks #26,794 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 16 technology areas.

#26,794
of 49,997 US assignees by volume: 48th percentile
by Innovation Score (34.4/100): 20.0
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26794 · US Corporation #26,794 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,794/49,997
PHOTO-FINISH Machines Dubuit
CPC-FOCUS G21G · 16 areas
INNOV-THIN 34.4/100
CLAIMS-DENSE 20.0 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Machines Dubuit (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Mallinckrodt’s 34.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (24%) Velocity 0.0 pts (0%) Breadth 14.1 pts (41%) Claim depth 12.0 pts (35%)

Qualcomm Incorporated · highest

85
Mallinckrodt… · this assignee

34
3D Lighting… · lowest

7

What this shows Mallinckrodt's Innovation Score is 34.4/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Mallinckrodt?

Each dot is one of Mallinckrodt’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Mallinckrodt’s own 20.0 claims/patent is ABOVE the 15.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Mallinckrodt vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Mallinckrodt's grants concentrate

Mallinckrodt Nuclear Medicine LLC is a focused PatentsView assignee: 16 CPC subclasses with 70% of grants classified under G21G (Conversion OF Chemical ELEMENTS; Radioactive Sources). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2016. By volume, Mallinckrodt sits between Machines Dubuit and Maruha Nichiro Corporation.

Machines Dubuit

10
Macnaught PTY

10
Maersk Container…

10
Magotteaux Intern…

10
MAM Holdings OF W…

10
Mammoet USA South

10
Marker Deutschland

10
Maruha Nichiro

10
Mallinckrodt Nucl… ◀

10

What this shows Mallinckrodt holds 10 patents at rank #26,782, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Mallinckrodt

By rank, the assignees closest to #26,782 in granted patent volume.

Leaders in G21G (Conversion OF Chemical Elements)

Other assignees with the most granted patents in Mallinckrodt's primary technology class.

Mallinckrodt's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 48th percentile higher than 48% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Mallinckrodt Nuclear Medicine LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	10.0%
2017	2	20.0%
2018	5	50.0%
2019	2	20.0%

Which technologies does Mallinckrodt Nuclear Medicine LLC patent most?

G21G - Conversion OF Chemical ELEMENTS; Radioactive Sources 7

G21F - Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation OR Particle BOMBARDMENT; Treating Radioactively Contaminated MATERIAL; Decontamination Arrangements Therefor 5

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 2

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 2

B01D - Separation 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

G06K - Graphical Data Reading ; Presentation OF DATA; Record CARRIERS; Handling Record Carriers 1

B66F - Hoisting, Lifting, Hauling OR Pushing, NOT Otherwise Provided FOR, e.g. Devices Which Apply A Lifting OR Pushing Force Directly TO THE Surface OF A Load 1

B65G - Transport OR Storage Devices, e.g. Conveyors FOR Loading OR Tipping, Shop Conveyor Systems OR Pneumatic Tube Conveyors 1

C22B - Production AND Refining OF Metals ; Pretreatment OF RAW Materials 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

B67D - Dispensing, Delivering OR Transferring Liquids, NOT Otherwise Provided FOR 1

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

C02F - Treatment OF Water, Waste Water, Sewage, OR Sludge 1

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Mallinckrodt Nuclear Medicine LLC's patent record in context - here's where to go next.

Mallinckrodt Nuclear Medicine LLC's lead technology class is G21G (Conversion OF Chemical ELEMENTS; Radioactive Sources), 70% of its portfolio - see every assignee active in that class. Explore G21G
Ranked #26,794 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Mallinckrodt Nuclear Medicine LLC against Machines Dubuit, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.